These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37042969)

  • 21. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.
    Lakatos L; Pandur T; David G; Balogh Z; Kuronya P; Tollas A; Lakatos PL
    World J Gastroenterol; 2003 Oct; 9(10):2300-7. PubMed ID: 14562397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients.
    Bandyopadhyay D; Bandyopadhyay S; Ghosh P; De A; Bhattacharya A; Dhali GK; Das K
    Indian J Gastroenterol; 2015 Sep; 34(5):387-94. PubMed ID: 26614005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermatologic manifestations in pediatric patients with inflammatory bowel disease.
    Afarideh M; Bartoletta K; Tollefson MM
    Pediatr Dermatol; 2024; 41(2):234-242. PubMed ID: 38326222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What are the risk factors for extraintestinal manifestations in inflammatory bowel diseases?
    Yeo MK; Park JH; Kang SH; Moon HS; Sung JK; Jeong HY; Kim JS
    Medicine (Baltimore); 2023 Mar; 102(9):e33031. PubMed ID: 36862909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
    Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
    Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease.
    Ciccacci C; Biancone L; Di Fusco D; Ranieri M; Condino G; Giardina E; Onali S; Lepre T; Pallone F; Novelli G; Borgiani P
    J Crohns Colitis; 2013 Feb; 7(1):44-52. PubMed ID: 22445837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the prevalence of uveitis between Crohn's disease and ulcerative colitis: A systematic review and meta-analysis.
    Lin H; Zhang J; Liang C; Wu D; Tan Y; Luo L; Liu Z
    Acta Ophthalmol; 2024 Jun; 102(4):e485-e492. PubMed ID: 37830172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease.
    Dubinsky MC; Cross RK; Sandborn WJ; Long M; Song X; Shi N; Ding Y; Eichner S; Pappalardo B; Ganguli A; Wang A
    Inflamm Bowel Dis; 2018 Aug; 24(9):1876-1882. PubMed ID: 29668916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations.
    He R; Zhao S; Cui M; Chen Y; Ma J; Li J; Wang X
    Front Immunol; 2023; 14():1234535. PubMed ID: 37954590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases.
    Colìa R; Corrado A; Cantatore FP
    Ann Med; 2016 Dec; 48(8):577-585. PubMed ID: 27310096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral arthritis in the course of inflammatory bowel diseases.
    Yüksel I; Ataseven H; Başar O; Köklü S; Ertuğrul I; Ulker A; Dağlı U; Saşmaz N
    Dig Dis Sci; 2011 Jan; 56(1):183-7. PubMed ID: 20458624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis.
    Jang HJ; Suh HR; Choi S; Hong SJ; Cho SM; Choi KH; Choe BH; Kang B;
    J Korean Med Sci; 2021 Nov; 36(44):e278. PubMed ID: 34783212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
    Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M
    Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.
    Vegh Z; Kurti Z; Gonczi L; Golovics PA; Lovasz BD; Szita I; Balogh M; Pandur T; Vavricka SR; Rogler G; Lakatos L; Lakatos PL
    Scand J Gastroenterol; 2016 Jul; 51(7):848-54. PubMed ID: 26880133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Incidence and risk factors of extraintestinal manifestations in children with inflammatory bowel disease].
    Shan CY; Zhang QQ; Xiao Y; Wang XQ; Yu Y; Xu X; Xu CD
    Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):694-699. PubMed ID: 31530355
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intestinal complications and extraintestinal manifestations in children with inflammatory bowel disease].
    Stawarski A; Iwańczak B; Krzesiek E; Iwańczak F
    Pol Merkur Lekarski; 2006 Jan; 20(115):22-5. PubMed ID: 16617729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cutaneous and mucosal manifestations of inflammatory bowel diseases].
    Károlyi Z; Erós N; Ujszászy L; Nagy G
    Orv Hetil; 2000 Jun; 141(25):1391-5. PubMed ID: 10934882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of fatigue with disease activity and clinical manifestations in patients with Crohn's disease and ulcerative colitis: an observational cross-sectional study in the United States.
    Gibble TH; Shan M; Zhou X; Naegeli AN; Dubey S; Lewis JD
    Curr Med Res Opin; 2024 Sep; 40(9):1537-1544. PubMed ID: 39037798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.